Evidence map›Paper›PMID 34550021›Full record

ArticleMicrobiology spectrum2021

Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak.

Yu Nakagama, Yuko Komase, Katherine Candray, Sachie Nakagama, Fumiaki Sano, Tomoya Tsuchida, Hiroyuki Kunishima, Takumi Imai, Ayumi Shintani, Yuko Nitahara and 2 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu NakagamaDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0001-9780-9719
Yuko KomaseDepartment of Respiratory Internal Medicine, St. Marianna University School of Medicinegrid.412764.2, Yokohama City Seibu Hospital, Yokohama, Japan.
Katherine CandrayDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Sachie NakagamaDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Fumiaki SanoDepartment of Hematology and Oncology, St. Marianna University School of Medicinegrid.412764.2, Yokohama City Seibu Hospital, Yokohama, Japan.
Tomoya TsuchidaDivision of General Internal Medicine, St. Marianna University School of Medicinegrid.412764.2, Kawasaki, Japan.
Hiroyuki KunishimaDepartment of Infectious Diseases, St. Marianna University School of Medicinegrid.412764.2, Kawasaki, Japan.
Takumi ImaiDepartment of Medical Statistics, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Ayumi ShintaniDepartment of Medical Statistics, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Yuko NitaharaDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0002-5026-478X
Natsuko KakuDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Yasutoshi KidoDepartment of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan.ORCID 0000-0003-3615-2631

Funding

BIKEN Taniguchi ScholarshipCOVID-19 Private Fund, Shinya Yamanaka LaboratoryJapan Agency for Medical Research and Development (AMED) JP20jk0110021Japan Agency for Medical Research and Development (AMED) JP20wm0125003Special Reserves Fund for COVID-19, Osaka City University
6 · The paper itself

Abstract

We describe the results of testing health care workers, from a tertiary care hospital in Japan that had experienced a coronavirus disease 2019 (COVID-19) outbreak during the first peak of the pandemic, for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody seroconversion. Using two chemiluminescent immunoassays and a confirmatory surrogate virus neutralization test, serological testing revealed that a surprising 42% of overlooked COVID-19 diagnoses (27/64 cases) occurred when case detection relied solely on SARS-CoV-2 nucleic acid amplification testing (NAAT). Our results suggest that the NAAT-positive population is only the tip of the iceberg and the portion left undetected might potentially have led to silent transmissions and triggered the spread. A questionnaire-based risk assessment was further indicative of exposures to specific aerosol-generating procedures (i.e., noninvasive ventilation and airway suctioning) having mediated transmission and served as the origins of the outbreak. Our observations are supportive of a multitiered testing approach, including the use of serological diagnostics, in order to accomplish exhaustive case detection along the whole COVID-19 spectrum.

Indexed as

AdultAntibodies, ViralCost of IllnessCOVID-19COVID-19 Nucleic Acid TestingCOVID-19 Serological TestingCross InfectionFemaleHealth PersonnelHumansImmunoglobulin GJapanMaleNeutralization TestsOccupational ExposureRisk AssessmentAntibodies, ViralImmunoglobulin GCOVID-19health care workersSARS-CoV-2serology

Identifiers

PMID34550021
PMCPMC8557877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.